Scrip is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Averion appoints Peter Gonze executive VP of global business development

This article was originally published in Scrip

Executive Summary

Averion International (US), a clinical research organisation specialising in oncology, cardiovascular diseases and medical devices, has appointed Peter Gonze executive vice-president of global business development. In the role, he will oversee the company's global business development and marketing activities, and will serve on its executive management team. For the past six years Mr Gonze has served as chief operating officer at Unither Pharmaceuticals.

Topics

Related Companies

Latest Headlines
See All
UsernamePublicRestriction

Register

SC002161

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel